GI Innovation announced on the 5th that it has recruited Hong Joon-ho, CEO of Interpark Bioconvergence (49), as management representative (COO, senior vice president).
Representative Hong is in charge of management, future strategy, investment attraction, and external cooperation at GI Innovation.
GI Innovation aims to strengthen its expertise in R&D and management through this recruitment and solidify its new drug development strategy, 3S (Strategy, Science, Speed).
Representative Hong has worked as a management consultant at Price Water House Coopers Consulting, and has been discovering new business as the head of the strategic planning team and the planning coordination department at the Interpark Group. In addition, he served as the head of the management support department and CEO of Ahnyeon Care, a drug distribution company that became a bridgehead for entry into the healthcare business of Interpark Group, and the first representative director of Interpark BioConvergence (IBCC), a new drug research and development company. It is evaluated as having a wide range of expertise in
Representative Hong said, “Gi Innovation is currently performing the most remarkable results among domestic bio companies. We support researchers at the forefront of R&D so that our pipelines can be successfully developed, We will make it a company that can compete.”
Chairman of GI Innovation Jang Myung-ho said, “By recruiting CEO Hong Joon-ho, the company is expected to gain momentum in its preparations for listing on the KOSDAQ.” “He said.
Meanwhile, on the 2nd, G-I Innovation has secured a strategic investment worth 20 billion won from iMarket Korea, a subsidiary of Interpark, and promised to strengthen the pipeline capabilities and continued cooperation between the two companies including Interpark BioConvergence.
Interpark BioConvergence is in the process of developing innovative new drugs, and through this strategic investment, it plans to solidify the cooperative relationship with GI Innovation, joint R&D, and business development.
GI Innovation said, “Pre-IPO is proceeding smoothly, with the goal of listing on the KOSDAQ in the second half of this year, following Yuhan Corporation’s 10 billion won strategic investment last month, and iMarket Korea’s 20 billion won strategic investment.” Said.